About Index Trending news
Analyze
Top 50 Pricing
PhaseRx

PhaseRx

Work at PhaseRx? Add yourself to this profile

PhaseRx

CEO of PhaseRx and former VC. PhaseRx is advancing mRNA therapeutics to treat orphan liver disease.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
IPO
$19,000,000
Venture capital (Series A)
$20,216,583
Employees

Unknown size

Locations
HQ
GeekWire

PhaseRx liver disease drug receives boost from FDA, stock soars

GeekWire

Geek of the Week: PhaseRx CEO Robert Overell is on a mission to save children with biotechnology

Science Technology